Supernus Pharmaceuticals Inc (SUPN)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt SUPN? Forum Prognose

Finanzdaten der Supernus Pharmaceuticals Inc-Aktie (SUPN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	6.65% 143.64	153.88	135.56	153.76	167.33
Cost Of Revenue	16.80% 16.31	19.60	21.09	23.46	-
Gross Profit	5.17% 127.33	134.28	114.47	130.30	-
Operating Expenses	3.45% 130.49	126.14	132.06	125.13	197.26
Interest Income/Expense	-	-	0.91	1.505	-
Benefits Costs and Expenses	0.41% 143.40	143.99	152.69	144.75	132.19
Costs And Expenses	0.72% 146.80	145.74	153.15	148.59	132.99
Depreciation and Amortization	0.00% 0.60	0.60	0.60	0.60	0.80
Operating Income/Loss	138.74% -3.153	8.138	-17.59	5.176	34.33
Nonoperating Income/Loss	93.95% 3.396	1.751	0.46	3.841	-
Income/Loss From Continuing Operations Before Tax	97.54% 0.243	9.889	-17.13	9.017	35.14
Income Tax Expense/Benefit, Deferred	40.84% -5.482	-9.266	-5.554	-0.435	-7.76
Income Tax Expense/Benefit	99.54% 0.119	25.86	-16.30	-7.931	9.659
Income/Loss From Continuing Operations After Tax	100.78% 0.124	-15.98	-0.831	16.95	25.48
Net Income/Loss	100.78% 0.124	-15.98	-0.831	16.95	25.48
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-0.892
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.35% 54.80	54.61	54.50	54.38	0.1473
Diluted Average Shares	1.86% 55.63	54.61	54.50	62.45	0.1367
Basic Earnings Per Share	100.00% -	-0.29	-0.02	0.31	0.47
Diluted Earnings Per Share	100.00% -	-0.29	-0.02	0.29	0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-0.892

ELAN

$12.67

0.88%

LNTH

$114.96

0.42%

ITCI

$89.24

3.56%

CTLT

$58.48

0.36%

NBIX

$121.53

0.83%

VTRS

$11.61

1.40%